APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anemia Screening Test

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Anemia Screening Test Market Outlook and Growth Opportunities 2026

3 May 2026194 pages

Choose your research edition.

Industry ResearchAnemia Screening Test Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal Anemia Screening Test Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Anemia Screening Test Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anemia Screening Test Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Anemia Screening Test Market Analysis and Forecast 2026-2032231 pages · $4,950 USD

Market perspective

The global Anemia Screening Test market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Anemia Screening Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Anemia Screening Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anemia Screening Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Anemia Screening Test market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Anemia Screening Test market include Quest Diagnostics, Labcorp, Eurofins Scientific, Sonic Healthcare, SYNLAB International, Unilabs, Abbott Diagnostics, Roche Diagnostics and Siemens Healthineers, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Anemia Screening Test market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Anemia Screening Test and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Anemia Screening Test revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Anemia Screening Test market.

Anemia Screening Test Segment by Company

Quest Diagnostics

Labcorp

Eurofins Scientific

Sonic Healthcare

SYNLAB International

Unilabs

Abbott Diagnostics

Roche Diagnostics

Siemens Healthineers

Beckman Coulter

Sysmex

Shenzhen Mindray Bio-Medical Electronics

Abbott Point of Care

Bio-Rad Laboratories

Streck Inc.

Daktari Diagnostics

BIOMEDOMICS

Request A Test Ltd

HemoCue India

HEALTH Gene Technology

Walk‑In Lab

Southside Pediatrics

Uber Diagnostics

SYNLAB

Anemia Screening Test Segment by Type

Whole Blood Test

Serum/Plasma Test

Anemia Screening Test Segment by Application

Medical and Health

Physical Examination

Public Health

Maternal and Child Health

Other

Anemia Screening Test Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Anemia Screening Test status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Anemia Screening Test key companies, revenue, market share, and recent developments.

3. To split the Anemia Screening Test breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Anemia Screening Test market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Anemia Screening Test significant trends, drivers, influence factors in global and regions.

6. To analyze Anemia Screening Test competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anemia Screening Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anemia Screening Test and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anemia Screening Test.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Anemia Screening Test industry.

Chapter 3: Detailed analysis of Anemia Screening Test company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Anemia Screening Test in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Anemia Screening Test in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Anemia Screening Test Industry Trends Table 2. Anemia Screening Test Industry Drivers Table 3. Anemia Screening Test Industry Opportunities and Challenges Table 4. Anemia Screening Test Industry Restraints Table 5. Global Anemia Screening Test Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Anemia Screening Test Revenue Share by Company (2021-2026) Table 7. Global Anemia Screening Test Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Anemia Screening Test Key Company Manufacturing Base & Headquarters Table 9. Global Anemia Screening Test Company, Product Type & Application Table 10. Global Anemia Screening Test Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Anemia Screening Test by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Whole Blood Test Table 15. Significant Companies of Serum/Plasma Test Table 16. Global Anemia Screening Test Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Anemia Screening Test Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Anemia Screening Test Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Anemia Screening Test Sales Value Share by Type (2021-2026) Table 20. Global Anemia Screening Test Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Medical and Health Table 22. Significant Companies of Physical Examination Table 23. Significant Companies of Public Health Table 24. Significant Companies of Maternal and Child Health Table 25. Significant Companies of Other Table 26. Global Anemia Screening Test Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Anemia Screening Test Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Anemia Screening Test Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Anemia Screening Test Sales Value Share by Application (2021-2026) Table 30. Global Anemia Screening Test Sales Value Share by Application (2027-2032) Table 31. Global Anemia Screening Test Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Anemia Screening Test Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Anemia Screening Test Sales Value Share by Region (2021-2026) Table 34. Global Anemia Screening Test Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Anemia Screening Test Sales Value Share by Region (2027-2032) Table 36. Global Anemia Screening Test Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Anemia Screening Test Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Anemia Screening Test Sales Value Market Share by Country (2021-2026) Table 39. Global Anemia Screening Test Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Anemia Screening Test Sales Value Market Share by Country (2027-2032) Table 41. Quest Diagnostics Company Information Table 42. Quest Diagnostics Business Overview Table 43. Quest Diagnostics Anemia Screening Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Quest Diagnostics Anemia Screening Test Product Portfolio Table 45. Quest Diagnostics Recent Development Table 46. Labcorp Company Information Table 47. Labcorp Business Overview Table 48. Labcorp Anemia Screening Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Labcorp Anemia Screening Test Product Portfolio Table 50. Labcorp Recent Development Table 51. Eurofins Scientific Company Information Table 52. Eurofins Scientific Business Overview Table 53. Eurofins Scientific Anemia Screening Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Eurofins Scientific Anemia Screening Test Product Portfolio Table 55. Eurofins Scientific Recent Development Table 56. Sonic Healthcare Company Information Table 57. Sonic Healthcare Business Overview Table 58. Sonic Healthcare Anemia Screening Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Sonic Healthcare Anemia Screening Test Product Portfolio Table 60. Sonic Healthcare Recent Development Table 61. SYNLAB International Company Information Table 62. SYNLAB International Business Overview Table 63. SYNLAB International Anemia Screening Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. SYNLAB International Anemia Screening Test Product Portfolio Table 65. SYNLAB International Recent Development Table 66. Unilabs Company Information Table 67. Unilabs Business Overview Table 68. Unilabs Anemia Screening Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Unilabs Anemia Screening Test Product Portfolio Table 70. Unilabs Recent Development Table 71. Abbott Diagnostics Company Information Table 72. Abbott Diagnostics Business Overview Table 73. Abbott Diagnostics Anemia Screening Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Abbott Diagnostics Anemia Screening Test Product Portfolio Table 75. Abbott Diagnostics Recent Development Table 76. Roche Diagnostics Company Information Table 77. Roche Diagnostics Business Overview Table 78. Roche Diagnostics Anemia Screening Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Roche Diagnostics Anemia Screening Test Product Portfolio Table 80. Roche Diagnostics Recent Development Table 81. Siemens Healthineers Company Information Table 82. Siemens Healthineers Business Overview Table 83. Siemens Healthineers Anemia Screening Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Siemens Healthineers Anemia Screening Test Product Portfolio Table 85. Siemens Healthineers Recent Development Table 86. Beckman Coulter Company Information Table 87. Beckman Coulter Business Overview Table 88. Beckman Coulter Anemia Screening Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Beckman Coulter Anemia Screening Test Product Portfolio Table 90. Beckman Coulter Recent Development Table 91. Sysmex Company Information Table 92. Sysmex Business Overview Table 93. Sysmex Anemia Screening Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Sysmex Anemia Screening Test Product Portfolio Table 95. Sysmex Recent Development Table 96. Shenzhen Mindray Bio-Medical Electronics Company Information Table 97. Shenzhen Mindray Bio-Medical Electronics Business Overview Table 98. Shenzhen Mindray Bio-Medical Electronics Anemia Screening Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Shenzhen Mindray Bio-Medical Electronics Anemia Screening Test Product Portfolio Table 100. Shenzhen Mindray Bio-Medical Electronics Recent Development Table 101. Abbott Point of Care Company Information Table 102. Abbott Point of Care Business Overview Table 103. Abbott Point of Care Anemia Screening Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Abbott Point of Care Anemia Screening Test Product Portfolio Table 105. Abbott Point of Care Recent Development Table 106. Bio-Rad Laboratories Company Information Table 107. Bio-Rad Laboratories Business Overview Table 108. Bio-Rad Laboratories Anemia Screening Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Bio-Rad Laboratories Anemia Screening Test Product Portfolio Table 110. Bio-Rad Laboratories Recent Development Table 111. Streck Inc. Company Information Table 112. Streck Inc. Business Overview Table 113. Streck Inc. Anemia Screening Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Streck Inc. Anemia Screening Test Product Portfolio Table 115. Streck Inc. Recent Development Table 116. Daktari Diagnostics Company Information Table 117. Daktari Diagnostics Business Overview Table 118. Daktari Diagnostics Anemia Screening Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Daktari Diagnostics Anemia Screening Test Product Portfolio Table 120. Daktari Diagnostics Recent Development Table 121. BIOMEDOMICS Company Information Table 122. BIOMEDOMICS Business Overview Table 123. BIOMEDOMICS Anemia Screening Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. BIOMEDOMICS Anemia Screening Test Product Portfolio Table 125. BIOMEDOMICS Recent Development Table 126. Request A Test Ltd Company Information Table 127. Request A Test Ltd Business Overview Table 128. Request A Test Ltd Anemia Screening Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Request A Test Ltd Anemia Screening Test Product Portfolio Table 130. Request A Test Ltd Recent Development Table 131. HemoCue India Company Information Table 132. HemoCue India Business Overview Table 133. HemoCue India Anemia Screening Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. HemoCue India Anemia Screening Test Product Portfolio Table 135. HemoCue India Recent Development Table 136. HEALTH Gene Technology Company Information Table 137. HEALTH Gene Technology Business Overview Table 138. HEALTH Gene Technology Anemia Screening Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. HEALTH Gene Technology Anemia Screening Test Product Portfolio Table 140. HEALTH Gene Technology Recent Development Table 141. Walk‑In Lab Company Information Table 142. Walk‑In Lab Business Overview Table 143. Walk‑In Lab Anemia Screening Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. Walk‑In Lab Anemia Screening Test Product Portfolio Table 145. Walk‑In Lab Recent Development Table 146. Southside Pediatrics Company Information Table 147. Southside Pediatrics Business Overview Table 148. Southside Pediatrics Anemia Screening Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 149. Southside Pediatrics Anemia Screening Test Product Portfolio Table 150. Southside Pediatrics Recent Development Table 151. Uber Diagnostics Company Information Table 152. Uber Diagnostics Business Overview Table 153. Uber Diagnostics Anemia Screening Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 154. Uber Diagnostics Anemia Screening Test Product Portfolio Table 155. Uber Diagnostics Recent Development Table 156. SYNLAB Company Information Table 157. SYNLAB Business Overview Table 158. SYNLAB Anemia Screening Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 159. SYNLAB Anemia Screening Test Product Portfolio Table 160. SYNLAB Recent Development Table 161. Research Programs/Design for This Report Table 162. Authors List of This Report Table 163. Secondary Sources Table 164. Primary Sources List of Figures Figure 1. Anemia Screening Test Product Image Figure 2. Global Anemia Screening Test Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anemia Screening Test Market Size (2021-2032) & (US$ Million) Figure 4. Global Anemia Screening Test Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Whole Blood Test Image Figure 8. Serum/Plasma Test Image Figure 9. Global Anemia Screening Test Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Anemia Screening Test Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Anemia Screening Test Sales Value Share by Type (2021-2032) Figure 12. Medical and Health Image Figure 13. Physical Examination Image Figure 14. Public Health Image Figure 15. Maternal and Child Health Image Figure 16. Other Image Figure 17. Global Anemia Screening Test Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Anemia Screening Test Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Anemia Screening Test Sales Value Share by Application (2021-2032) Figure 20. Global Anemia Screening Test Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Anemia Screening Test Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Anemia Screening Test Sales Value (2021-2032) & (US$ Million) Figure 23. North America Anemia Screening Test Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Anemia Screening Test Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Anemia Screening Test Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Anemia Screening Test Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Anemia Screening Test Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Anemia Screening Test Sales Value (2021-2032) & (US$ Million) Figure 29. South America Anemia Screening Test Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Anemia Screening Test Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Anemia Screening Test Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Anemia Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Anemia Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Anemia Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Anemia Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Anemia Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Anemia Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Anemia Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Anemia Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Anemia Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Anemia Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Anemia Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Anemia Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Anemia Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Anemia Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Anemia Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Anemia Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Anemia Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Anemia Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Anemia Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Anemia Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Anemia Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Anemia Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Anemia Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Anemia Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Anemia Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Anemia Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Anemia Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Anemia Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Anemia Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Anemia Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Anemia Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Anemia Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Anemia Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Anemia Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Anemia Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Anemia Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Anemia Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Anemia Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Anemia Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Anemia Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Anemia Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Anemia Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Anemia Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Anemia Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Anemia Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Anemia Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Anemia Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Anemia Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Anemia Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Anemia Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Anemia Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Anemia Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Anemia Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Anemia Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Anemia Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Anemia Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Anemia Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Anemia Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Anemia Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Anemia Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Anemia Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Anemia Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Anemia Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Anemia Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Anemia Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Anemia Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Anemia Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Anemia Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Anemia Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Anemia Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Anemia Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Anemia Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Anemia Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Anemia Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Anemia Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Anemia Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Anemia Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Anemia Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Anemia Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Anemia Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Anemia Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Anemia Screening Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Anemia Screening Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Anemia Screening Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Whole Blood Test
  • Serum/Plasma Test
Applications
  • Medical and Health
  • Physical Examination
  • Public Health
  • Maternal and Child Health
  • Other
Companies covered
  • Quest Diagnostics
  • Labcorp
  • Eurofins Scientific
  • Sonic Healthcare
  • SYNLAB International
  • Unilabs
  • Abbott Diagnostics
  • Roche Diagnostics
  • Siemens Healthineers
  • Beckman Coulter
  • Sysmex
  • Shenzhen Mindray Bio-Medical Electronics
  • Abbott Point of Care
  • Bio-Rad Laboratories
  • Streck Inc.
  • Daktari Diagnostics
  • BIOMEDOMICS
  • Request A Test Ltd
  • HemoCue India
  • HEALTH Gene Technology
  • Walk‑In Lab
  • Southside Pediatrics
  • Uber Diagnostics
  • SYNLAB

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Anemia Screening Test Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Anemia Screening Test Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Anemia Screening Test Market Dynamics
  1. 2.1 Anemia Screening Test Industry Trends
  2. 2.2 Anemia Screening Test Industry Drivers
  3. 2.3 Anemia Screening Test Industry Opportunities and Challenges
  4. 2.4 Anemia Screening Test Industry Restraints
3 Anemia Screening Test Market by Company
  1. 3.1 Global Anemia Screening Test Company Revenue Ranking in 2025
  2. 3.2 Global Anemia Screening Test Revenue by Company (2021-2026)
  3. 3.3 Global Anemia Screening Test Company Ranking (2024-2026)
  4. 3.4 Global Anemia Screening Test Company Manufacturing Base and Headquarters
  5. 3.5 Global Anemia Screening Test Company Product Type and Application
  6. 3.6 Global Anemia Screening Test Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Anemia Screening Test Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Anemia Screening Test Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Anemia Screening Test Market by Type
  1. 4.1 Anemia Screening Test Type Introduction
  2. 4.1.1 Whole Blood Test
  3. 4.1.2 Serum/Plasma Test
  4. 4.2 Global Anemia Screening Test Sales Value by Type
  5. 4.2.1 Global Anemia Screening Test Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Anemia Screening Test Sales Value by Type (2021-2032)
  7. 4.2.3 Global Anemia Screening Test Sales Value Share by Type (2021-2032)
5 Anemia Screening Test Market by Application
  1. 5.1 Anemia Screening Test Application Introduction
  2. 5.1.1 Medical and Health
  3. 5.1.2 Physical Examination
  4. 5.1.3 Public Health
  5. 5.1.4 Maternal and Child Health
  6. 5.1.5 Other
  7. 5.2 Global Anemia Screening Test Sales Value by Application
  8. 5.2.1 Global Anemia Screening Test Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Anemia Screening Test Sales Value by Application (2021-2032)
  10. 5.2.3 Global Anemia Screening Test Sales Value Share by Application (2021-2032)
6 Anemia Screening Test Regional Value Analysis
  1. 6.1 Global Anemia Screening Test Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Anemia Screening Test Sales Value by Region (2021-2032)
  3. 6.2.1 Global Anemia Screening Test Sales Value by Region: 2021-2026
  4. 6.2.2 Global Anemia Screening Test Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Anemia Screening Test Sales Value (2021-2032)
  7. 6.3.2 North America Anemia Screening Test Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Anemia Screening Test Sales Value (2021-2032)
  10. 6.4.2 Europe Anemia Screening Test Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Anemia Screening Test Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Anemia Screening Test Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Anemia Screening Test Sales Value (2021-2032)
  16. 6.6.2 South America Anemia Screening Test Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Anemia Screening Test Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Anemia Screening Test Sales Value Share by Country, 2025 VS 2032
7 Anemia Screening Test Country-level Value Analysis
  1. 7.1 Global Anemia Screening Test Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Anemia Screening Test Sales Value by Country (2021-2032)
  3. 7.2.1 Global Anemia Screening Test Sales Value by Country (2021-2026)
  4. 7.2.2 Global Anemia Screening Test Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Anemia Screening Test Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Anemia Screening Test Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Anemia Screening Test Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Anemia Screening Test Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Anemia Screening Test Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Anemia Screening Test Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Anemia Screening Test Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Anemia Screening Test Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Anemia Screening Test Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Anemia Screening Test Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Anemia Screening Test Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Anemia Screening Test Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Anemia Screening Test Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Anemia Screening Test Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Anemia Screening Test Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Anemia Screening Test Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Anemia Screening Test Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Anemia Screening Test Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Anemia Screening Test Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Anemia Screening Test Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Anemia Screening Test Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Anemia Screening Test Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Anemia Screening Test Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Anemia Screening Test Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Anemia Screening Test Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Anemia Screening Test Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Anemia Screening Test Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Anemia Screening Test Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Anemia Screening Test Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Anemia Screening Test Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Anemia Screening Test Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Anemia Screening Test Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Anemia Screening Test Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Anemia Screening Test Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Anemia Screening Test Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Anemia Screening Test Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Anemia Screening Test Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Anemia Screening Test Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Anemia Screening Test Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Anemia Screening Test Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Anemia Screening Test Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Anemia Screening Test Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Anemia Screening Test Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Anemia Screening Test Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Anemia Screening Test Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Anemia Screening Test Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Anemia Screening Test Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Anemia Screening Test Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Anemia Screening Test Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Anemia Screening Test Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Anemia Screening Test Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Anemia Screening Test Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Anemia Screening Test Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Anemia Screening Test Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Anemia Screening Test Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Anemia Screening Test Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Anemia Screening Test Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Anemia Screening Test Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Anemia Screening Test Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Anemia Screening Test Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Anemia Screening Test Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Anemia Screening Test Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Anemia Screening Test Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Anemia Screening Test Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Anemia Screening Test Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Anemia Screening Test Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Anemia Screening Test Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Anemia Screening Test Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Anemia Screening Test Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Anemia Screening Test Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Anemia Screening Test Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Anemia Screening Test Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Anemia Screening Test Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Anemia Screening Test Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Anemia Screening Test Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Anemia Screening Test Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Anemia Screening Test Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Anemia Screening Test Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Anemia Screening Test Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Anemia Screening Test Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Anemia Screening Test Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Anemia Screening Test Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Anemia Screening Test Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Anemia Screening Test Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Quest Diagnostics
  2. 8.1.1 Quest Diagnostics Company Information
  3. 8.1.2 Quest Diagnostics Business Overview
  4. 8.1.3 Quest Diagnostics Anemia Screening Test Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Quest Diagnostics Anemia Screening Test Product Portfolio
  6. 8.1.5 Quest Diagnostics Recent Developments
  7. 8.2 Labcorp
  8. 8.2.1 Labcorp Company Information
  9. 8.2.2 Labcorp Business Overview
  10. 8.2.3 Labcorp Anemia Screening Test Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Labcorp Anemia Screening Test Product Portfolio
  12. 8.2.5 Labcorp Recent Developments
  13. 8.3 Eurofins Scientific
  14. 8.3.1 Eurofins Scientific Company Information
  15. 8.3.2 Eurofins Scientific Business Overview
  16. 8.3.3 Eurofins Scientific Anemia Screening Test Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Eurofins Scientific Anemia Screening Test Product Portfolio
  18. 8.3.5 Eurofins Scientific Recent Developments
  19. 8.4 Sonic Healthcare
  20. 8.4.1 Sonic Healthcare Company Information
  21. 8.4.2 Sonic Healthcare Business Overview
  22. 8.4.3 Sonic Healthcare Anemia Screening Test Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sonic Healthcare Anemia Screening Test Product Portfolio
  24. 8.4.5 Sonic Healthcare Recent Developments
  25. 8.5 SYNLAB International
  26. 8.5.1 SYNLAB International Company Information
  27. 8.5.2 SYNLAB International Business Overview
  28. 8.5.3 SYNLAB International Anemia Screening Test Revenue and Gross Margin (2021-2026)
  29. 8.5.4 SYNLAB International Anemia Screening Test Product Portfolio
  30. 8.5.5 SYNLAB International Recent Developments
  31. 8.6 Unilabs
  32. 8.6.1 Unilabs Company Information
  33. 8.6.2 Unilabs Business Overview
  34. 8.6.3 Unilabs Anemia Screening Test Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Unilabs Anemia Screening Test Product Portfolio
  36. 8.6.5 Unilabs Recent Developments
  37. 8.7 Abbott Diagnostics
  38. 8.7.1 Abbott Diagnostics Company Information
  39. 8.7.2 Abbott Diagnostics Business Overview
  40. 8.7.3 Abbott Diagnostics Anemia Screening Test Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Abbott Diagnostics Anemia Screening Test Product Portfolio
  42. 8.7.5 Abbott Diagnostics Recent Developments
  43. 8.8 Roche Diagnostics
  44. 8.8.1 Roche Diagnostics Company Information
  45. 8.8.2 Roche Diagnostics Business Overview
  46. 8.8.3 Roche Diagnostics Anemia Screening Test Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Roche Diagnostics Anemia Screening Test Product Portfolio
  48. 8.8.5 Roche Diagnostics Recent Developments
  49. 8.9 Siemens Healthineers
  50. 8.9.1 Siemens Healthineers Company Information
  51. 8.9.2 Siemens Healthineers Business Overview
  52. 8.9.3 Siemens Healthineers Anemia Screening Test Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Siemens Healthineers Anemia Screening Test Product Portfolio
  54. 8.9.5 Siemens Healthineers Recent Developments
  55. 8.10 Beckman Coulter
  56. 8.10.1 Beckman Coulter Company Information
  57. 8.10.2 Beckman Coulter Business Overview
  58. 8.10.3 Beckman Coulter Anemia Screening Test Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Beckman Coulter Anemia Screening Test Product Portfolio
  60. 8.10.5 Beckman Coulter Recent Developments
  61. 8.11 Sysmex
  62. 8.11.1 Sysmex Company Information
  63. 8.11.2 Sysmex Business Overview
  64. 8.11.3 Sysmex Anemia Screening Test Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sysmex Anemia Screening Test Product Portfolio
  66. 8.11.5 Sysmex Recent Developments
  67. 8.12 Shenzhen Mindray Bio-Medical Electronics
  68. 8.12.1 Shenzhen Mindray Bio-Medical Electronics Company Information
  69. 8.12.2 Shenzhen Mindray Bio-Medical Electronics Business Overview
  70. 8.12.3 Shenzhen Mindray Bio-Medical Electronics Anemia Screening Test Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Shenzhen Mindray Bio-Medical Electronics Anemia Screening Test Product Portfolio
  72. 8.12.5 Shenzhen Mindray Bio-Medical Electronics Recent Developments
  73. 8.13 Abbott Point of Care
  74. 8.13.1 Abbott Point of Care Company Information
  75. 8.13.2 Abbott Point of Care Business Overview
  76. 8.13.3 Abbott Point of Care Anemia Screening Test Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Abbott Point of Care Anemia Screening Test Product Portfolio
  78. 8.13.5 Abbott Point of Care Recent Developments
  79. 8.14 Bio-Rad Laboratories
  80. 8.14.1 Bio-Rad Laboratories Company Information
  81. 8.14.2 Bio-Rad Laboratories Business Overview
  82. 8.14.3 Bio-Rad Laboratories Anemia Screening Test Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Bio-Rad Laboratories Anemia Screening Test Product Portfolio
  84. 8.14.5 Bio-Rad Laboratories Recent Developments
  85. 8.15 Streck Inc.
  86. 8.15.1 Streck Inc. Company Information
  87. 8.15.2 Streck Inc. Business Overview
  88. 8.15.3 Streck Inc. Anemia Screening Test Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Streck Inc. Anemia Screening Test Product Portfolio
  90. 8.15.5 Streck Inc. Recent Developments
  91. 8.16 Daktari Diagnostics
  92. 8.16.1 Daktari Diagnostics Company Information
  93. 8.16.2 Daktari Diagnostics Business Overview
  94. 8.16.3 Daktari Diagnostics Anemia Screening Test Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Daktari Diagnostics Anemia Screening Test Product Portfolio
  96. 8.16.5 Daktari Diagnostics Recent Developments
  97. 8.17 BIOMEDOMICS
  98. 8.17.1 BIOMEDOMICS Company Information
  99. 8.17.2 BIOMEDOMICS Business Overview
  100. 8.17.3 BIOMEDOMICS Anemia Screening Test Revenue and Gross Margin (2021-2026)
  101. 8.17.4 BIOMEDOMICS Anemia Screening Test Product Portfolio
  102. 8.17.5 BIOMEDOMICS Recent Developments
  103. 8.18 Request A Test Ltd
  104. 8.18.1 Request A Test Ltd Company Information
  105. 8.18.2 Request A Test Ltd Business Overview
  106. 8.18.3 Request A Test Ltd Anemia Screening Test Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Request A Test Ltd Anemia Screening Test Product Portfolio
  108. 8.18.5 Request A Test Ltd Recent Developments
  109. 8.19 HemoCue India
  110. 8.19.1 HemoCue India Company Information
  111. 8.19.2 HemoCue India Business Overview
  112. 8.19.3 HemoCue India Anemia Screening Test Revenue and Gross Margin (2021-2026)
  113. 8.19.4 HemoCue India Anemia Screening Test Product Portfolio
  114. 8.19.5 HemoCue India Recent Developments
  115. 8.20 HEALTH Gene Technology
  116. 8.20.1 HEALTH Gene Technology Company Information
  117. 8.20.2 HEALTH Gene Technology Business Overview
  118. 8.20.3 HEALTH Gene Technology Anemia Screening Test Revenue and Gross Margin (2021-2026)
  119. 8.20.4 HEALTH Gene Technology Anemia Screening Test Product Portfolio
  120. 8.20.5 HEALTH Gene Technology Recent Developments
  121. 8.21 Walk‑In Lab
  122. 8.21.1 Walk‑In Lab Company Information
  123. 8.21.2 Walk‑In Lab Business Overview
  124. 8.21.3 Walk‑In Lab Anemia Screening Test Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Walk‑In Lab Anemia Screening Test Product Portfolio
  126. 8.21.5 Walk‑In Lab Recent Developments
  127. 8.22 Southside Pediatrics
  128. 8.22.1 Southside Pediatrics Company Information
  129. 8.22.2 Southside Pediatrics Business Overview
  130. 8.22.3 Southside Pediatrics Anemia Screening Test Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Southside Pediatrics Anemia Screening Test Product Portfolio
  132. 8.22.5 Southside Pediatrics Recent Developments
  133. 8.23 Uber Diagnostics
  134. 8.23.1 Uber Diagnostics Company Information
  135. 8.23.2 Uber Diagnostics Business Overview
  136. 8.23.3 Uber Diagnostics Anemia Screening Test Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Uber Diagnostics Anemia Screening Test Product Portfolio
  138. 8.23.5 Uber Diagnostics Recent Developments
  139. 8.24 SYNLAB
  140. 8.24.1 SYNLAB Company Information
  141. 8.24.2 SYNLAB Business Overview
  142. 8.24.3 SYNLAB Anemia Screening Test Revenue and Gross Margin (2021-2026)
  143. 8.24.4 SYNLAB Anemia Screening Test Product Portfolio
  144. 8.24.5 SYNLAB Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst